Lensar (LNSR) Net Margin Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 5,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,203.00 |
| Dec 31, 2025 | 1,524.00 |
| Sep 30, 2025 | 3,448.00 |
| Jun 30, 2025 | 8,770.00 |
| Mar 31, 2025 | -10,908.00 |
| Dec 31, 2024 | -9,974.00 |
| Sep 30, 2024 | 6,331.00 |
| Jun 30, 2024 | -2,032.00 |
| Mar 31, 2024 | -65,644.00 |
| Dec 31, 2023 | 2,582.00 |
| Sep 30, 2023 | 8,129.00 |
| Jun 30, 2023 | 1,623.00 |
| Mar 31, 2023 | 1,064.00 |
| Dec 31, 2022 | -312.00 |
| Sep 30, 2022 | 852.00 |